Zehnte Österreichische Ärztetagung Wien 1957
DOI: 10.1007/978-3-7091-5079-5_9
|View full text |Cite
|
Sign up to set email alerts
|

Ergebnisse der intravenösen Implantation von Impftumoren

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1958
1958
1961
1961

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…Unaware of this work, we started a series of experiments in 1955 in order to find out if the mortality rate due to secondary growth following radical operation could be decreased by means of postoperative chemotherapy. Results of these experiments have been published elsewhere.13, 14, [42][43][44][45][46] At first a series of experiments was performed on 4,000 rats and 1,250 mice imitating the invasion of tumor cells into the blood stream and its consequences in human patients. We injected 1 to 2 million cells of reticulum cell-like sarcoma Yoshida, carcinosarcoma 256 Walker, or ascites tumor Ehrlich into the tail vein, obtaining tumor growth in 80 to l O O~& T h e animals died in 10 to 20 From the Austrian Cancer Research Institute, Vienna, Austria.…”
mentioning
confidence: 99%
“…Unaware of this work, we started a series of experiments in 1955 in order to find out if the mortality rate due to secondary growth following radical operation could be decreased by means of postoperative chemotherapy. Results of these experiments have been published elsewhere.13, 14, [42][43][44][45][46] At first a series of experiments was performed on 4,000 rats and 1,250 mice imitating the invasion of tumor cells into the blood stream and its consequences in human patients. We injected 1 to 2 million cells of reticulum cell-like sarcoma Yoshida, carcinosarcoma 256 Walker, or ascites tumor Ehrlich into the tail vein, obtaining tumor growth in 80 to l O O~& T h e animals died in 10 to 20 From the Austrian Cancer Research Institute, Vienna, Austria.…”
mentioning
confidence: 99%